# Risk: __Shortage of COVID-19 testing kits__ (PBN__Risk_353)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [manufacturing companies](../Technology/PBN__Technology_1084)
* [logistics providers](../Technology/PBN__Technology_1085)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskOwner

* [manufacturing companies](../Stakeholder/PBN__Stakeholder_1152)
* [governments](../Stakeholder/PBN__Stakeholder_47)

## Property: has_RiskMitigation

* [Development of IoMT applications](../RiskMitigation/PBN__RiskMitigation_464)
* [Increase production and distribution of testing kits](../RiskMitigation/PBN__RiskMitigation_2284)

## Property: has_RiskName

Slows down diagnosis and containment efforts

## Property: has_RiskDescription

Lack of availability and access to testing kits for prompt and widespread testing

## Property: has_RiskSource

* [mbunge_critical_2021](../Article/PBN__Article_91)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

